This paper is in the following e-collection/theme issue:

RCTs - Protocols/Proposals (funded, already peer-reviewed, non-eHealth) (172)

Published on in Vol 6, No 9 (2017): September

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/8631, first published .
Comparing the Effects of Oral Contraceptives Containing Levonorgestrel With Products Containing Antiandrogenic Progestins on Clinical, Hormonal, and Metabolic Parameters and Quality of Life in Women With Polycystic Ovary Syndrome: Crossover Randomized Controlled Trial Protocol

Comparing the Effects of Oral Contraceptives Containing Levonorgestrel With Products Containing Antiandrogenic Progestins on Clinical, Hormonal, and Metabolic Parameters and Quality of Life in Women With Polycystic Ovary Syndrome: Crossover Randomized Controlled Trial Protocol

Comparing the Effects of Oral Contraceptives Containing Levonorgestrel With Products Containing Antiandrogenic Progestins on Clinical, Hormonal, and Metabolic Parameters and Quality of Life in Women With Polycystic Ovary Syndrome: Crossover Randomized Controlled Trial Protocol

Authors of this article:

Mina Amiri1, 2 Author Orcid Image ;   Fatemeh Nahidi1 Author Orcid Image ;   Davood Khalili3 Author Orcid Image ;   Razieh Bidhendi-Yarandi2, 4 Author Orcid Image ;   Fahimeh Ramezani Tehrani2 Author Orcid Image
Article Authors Cited by (2) Tweetations (2) Metrics

Mina Amiri   1, 2 , PhD ;   Fatemeh Nahidi   1 , PhD ;   Davood Khalili   3 , MD, PhD ;   Razieh Bidhendi-Yarandi   2, 4 , PhD ;   Fahimeh Ramezani Tehrani   2 , MD

1 Department of Midwifery and Reproductive Health, Faculty of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Tehran, Iran

2 Reproductive Endocrinology Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran

3 Prevention of Metabolic Disorders Research Center, Research Institute for Endocrine Science, Shahid Beheshti University of Medical Sciences, Tehran, Iran

4 Department of Epidemiology and Biostatistics, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran

Corresponding Author:

  • Fahimeh Ramezani Tehrani, MD
  • Reproductive Endocrinology Research Center
  • Research Institute for Endocrine Sciences
  • Shahid Beheshti University of Medical Sciences
  • 24 Parvaneh, Yaman Street, Velenjak
  • P.O. Box 19395-4763
  • Tehran
  • Iran
  • Phone: 98 2243 2500
  • Email: ramezani@endocrine.ac.ir